EYPT vs. SPY
Compare and contrast key facts about Eyepoint Pharmaceuticals Inc (EYPT) and SPDR S&P 500 ETF (SPY).
SPY is a passively managed fund by State Street that tracks the performance of the S&P 500 Index. It was launched on Jan 22, 1993.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: EYPT or SPY.
Correlation
The correlation between EYPT and SPY is 0.21, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
EYPT vs. SPY - Performance Comparison
Key characteristics
EYPT:
-0.86
SPY:
1.75
EYPT:
-1.55
SPY:
2.36
EYPT:
0.80
SPY:
1.32
EYPT:
-0.79
SPY:
2.66
EYPT:
-1.25
SPY:
11.01
EYPT:
62.35%
SPY:
2.03%
EYPT:
90.79%
SPY:
12.77%
EYPT:
-99.43%
SPY:
-55.19%
EYPT:
-98.47%
SPY:
-2.12%
Returns By Period
In the year-to-date period, EYPT achieves a -17.45% return, which is significantly lower than SPY's 2.36% return. Over the past 10 years, EYPT has underperformed SPY with an annualized return of -18.01%, while SPY has yielded a comparatively higher 12.96% annualized return.
EYPT
-17.45%
-29.47%
-33.08%
-76.44%
-15.80%
-18.01%
SPY
2.36%
-1.07%
7.41%
19.73%
14.21%
12.96%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
EYPT vs. SPY — Risk-Adjusted Performance Rank
EYPT
SPY
EYPT vs. SPY - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Eyepoint Pharmaceuticals Inc (EYPT) and SPDR S&P 500 ETF (SPY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
EYPT vs. SPY - Dividend Comparison
EYPT has not paid dividends to shareholders, while SPY's dividend yield for the trailing twelve months is around 1.18%.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
EYPT Eyepoint Pharmaceuticals Inc | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
SPY SPDR S&P 500 ETF | 1.18% | 1.21% | 1.40% | 1.65% | 1.20% | 1.52% | 1.75% | 2.04% | 1.80% | 2.03% | 2.06% | 1.87% |
Drawdowns
EYPT vs. SPY - Drawdown Comparison
The maximum EYPT drawdown since its inception was -99.43%, which is greater than SPY's maximum drawdown of -55.19%. Use the drawdown chart below to compare losses from any high point for EYPT and SPY. For additional features, visit the drawdowns tool.
Volatility
EYPT vs. SPY - Volatility Comparison
Eyepoint Pharmaceuticals Inc (EYPT) has a higher volatility of 21.44% compared to SPDR S&P 500 ETF (SPY) at 3.38%. This indicates that EYPT's price experiences larger fluctuations and is considered to be riskier than SPY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.